WW+E Celebrates Banner Year of High Stakes Trial Wins By Next Generation Of Trial Lawyers

wwe Homepage news, News, News

WASHINGTON – Wilkinson Walsh + Eskovitz is racing into its fourth year after notching a series of high-profile victories, led by a large and diverse group of partners. In 2018, all of WW+E’s partners participated in trials and case-dispositive hearings, and several other attorneys achieved significant on-their-feet experience, including through pro bono cases. The firm earned repeated recognition for the depth and successes of its bench and added a new crop of talented litigators to its roster. WW+E won three trials in 2018, each of which was first-chaired by a different partner: On April 27, 2018, WW+E, led by Brian Stekloff, Jeremy Barber, and Lori McGill, won a unanimous defense verdict for Bayer and Johnson & Johnson subsidiary Janssen Pharmaceuticals in Russell v. Janssen Pharmaceuticals, Inc., the second state-court Xarelto bellwether trial in the Pennsylvania Court of Common Pleas. On May 21, 2018, WW+E, led by Kosta Stojilkovic and Rakesh …

WWE PARTNER ALEXANDRA WALSH NAMED LITIGATOR OF THE WEEK

wwe Homepage news, News, News

Award recognizes her role leading the Wilkinson, Walsh + Eskovitz team to another victory WASHINGTON – Litigation Daily selected Wilkinson Walsh + Eskovitz Founding Partner Alexandra Walsh as its Litigator of the Week for her role persuading a Philadelphia jury to find for the defense in a bellwether trial over the adequacy of the warning labels for the blood thinner Xarelto. Walsh, along with partners Tamarra Matthews Johnson and Rakesh Kilaru, won the third state-court bellwether trial over the blood- thinner Xarelto in the Pennsylvania Court of Common Pleas in August. The victory was the third win for Bayer in state court, and the sixth win overall, in the Xarelto litigation. Read her Q&A with Lit Daily Editor Jenna Greene here. Walsh and Johnson served as lead trial counsel for Bayer, and Kilaru helped direct the legal strategy. A 12-member jury in Philadelphia returned a defense verdict after less than …

Wilkinson Walsh Secures Another Trial Victory for Bayer in Xarelto Trial

wwe Homepage news, News

Alexandra Walsh, co-founding partner of Wilkinson, Walsh + Eskovitz, Tamarra Matthews Johnson, and Rakesh Kilaru led the defense team to another victory. WASHINGTON – The Wilkinson Walsh + Eskovitz trial team, led by Founding Partner Alexandra Walsh and partners Tamarra Matthews Johnson and Rakesh Kilaru, won the third state-court bellwether trial over the blood- thinner Xarelto in the Pennsylvania Court of Common Pleas. This is the third win for Bayer in state court, and the sixth win overall, in the Xarelto litigation. The Plaintiff, Kevin Cooney, alleged that Bayer and Johnson & Johnson subsidiary Janssen Pharmaceuticals were liable for claims that the Xarelto label did not adequately warn or instruct doctors on the risks of bleeding associated with the anticoagulant medicine Xarelto. Walsh and Johnson served as lead trial counsel for Bayer, and Kilaru helped direct the legal strategy. A 12-member jury in Philadelphia returned a defense verdict after less …